Sat.Oct 19, 2024 - Fri.Oct 25, 2024

article thumbnail

Pharmacists asked to help shape NHS 10-year plan

The Pharmacist

Pharmacists, other health professionals and the general public have been invited to respond to a national 'engagement exercise' to help shape the government's 10-year plan for the NHS. Prime Minister Sir Keir Starmer said today that while the government has 'a clear plan to fix the health service', it was 'only right that we hear […] The post Pharmacists asked to help shape NHS 10-year plan appeared first on The Pharmacist.

95
article thumbnail

Opinion: ‘Do no harm’ is hurting 400 million long Covid patients worldwide

STAT

Imagine, for a moment, that you wake up one morning with a debilitating illness that won’t let go. Weeks and months pass, but the crushing fatigue, constant headaches, and aching muscles remain. You can’t think straight. Simply showering or doing the dishes leaves you floored for days at a time, and the unpredictable symptoms — shortness of breath, dizziness, a racing heart — ebb and flow without warning.

364
364
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Embedding into the provider’s workflow is key to a specialty drug’s success

PharmaVoice

Providers struggle with time-consuming processes. Patients are waiting for therapy. Embedded EMR system solutions can streamline therapy initiation and improve outcomes.

246
246
article thumbnail

SAEM Clinical Images Series: When Needles Go Beyond Sewing and Acupuncture

ALiEM - Pharm Pearls

A 64-year-old male with a history of bipolar 1 disorder, PTSD, anxiety, depression, obsessive-compulsive disorder, GERD, and HTN presented to the ED with the chief complaint of foreign body and self-injury. He reported years of sticking sewing needles into his right arm, most recently yesterday. He explained that inserting needles makes him feel better with mild associated pain.

Vaccines 177
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

RNA editing: emerging from CRISPR’s shadow

BioPharma Dive

Early study data from Wave Life Sciences suggests how editing RNA may yield viable medicines. Large and small drugmakers say such results are just the start.

141
141
article thumbnail

STAT+: For the behemoth UnitedHealth, a new threat to Medicare profits

STAT

For the nation’s largest health insurer, the evidence of abuse was stunning and unmistakable: UnitedHealth Group reaped billions from the federal Medicare program by diagnosing patients with serious chronic illnesses, and then delivering no follow-up care. The findings in the federal report reveal that UnitedHealth repeatedly sent clinicians into patients’ homes and pored over their medical charts to add diagnoses for illnesses such as vascular disease, heart failure, and diabetes.

Diabetes 363

More Trending

article thumbnail

SAEM Clinical Images Series: Not Your Average Ear Infection

ALiEM - Pharm Pearls

A 5-year-old generally healthy fully immunized boy presented to the ED with worsening left ear redness, swelling, and tenderness that his family noticed the day before presentation. His family had also recently noticed an abrasion over that ear. The patient was on amoxicillin for strep throat, which was diagnosed a week before the onset of his symptoms and was improving.

article thumbnail

AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced

The Guardian - Pharmaceutical Industry

Biotech giant’s alleged comments come as world leaders at Cop16 discuss how to share benefits from genetic code discoveries fairly AstraZeneca has said it may cut jobs at its UK operation if the government enforces a global push to make companies share profits derived from nature’s genetic codes, multiple sources have told the Guardian. The alleged comments from the company came amid a concerted lobbying push by the pharmaceutical industry against the profit-sharing measures.

124
124
article thumbnail

STAT+: UnitedHealth was top insurer collecting billions in questionable Medicare payments, federal watchdog finds

STAT

A federal watchdog found that Medicare Advantage insurers collected billions of dollars in dubious payments from Medicare in a single year by using home visits and medical chart reviews to diagnose patients with conditions for which they received no follow-up care.    A report released Thursday by the Office of Inspector General for the Health and Human Services Department concluded that insurers collectively received an estimated $7.5 billion in payments last year from so-called

article thumbnail

FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage

PharmaVoice

After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Intellia data spark debate about CRISPR drug’s potential

BioPharma Dive

Newly published data show the therapy reduced the rate of swelling attacks in people with hereditary angioedema, but didn't silence questions about its commercial outlook.

118
118
article thumbnail

Otsuka eyes early filing of IgAN drug after phase 3 readout

pharmaphorum

Otsuka is hoping to file for approval of its anti-APRIL antibody sibeprenlimab as a treatment for kidney disorder IgA nephropathy (IgAN) after the drug hit the target in a phase 3 trial.The Japanese drugmaker said that interim results from the 530-patient VISIONARY study showed that sibeprenlimab achieved a statistically significant and clinically meaningful reduction in 24-hour urine protein-to-creatine ratio (uPCR) – a measure of how well the kidneys are working – after nine months of treatmen

119
119
article thumbnail

In the era of GLP-1 drugs, demand for bariatric surgery plunges

STAT

For people with obesity, surgeries that shrink, reshape, or otherwise alter the anatomy of the stomach have long reigned supreme as the surest way to weight loss. But in the last few years, with the approval of GLP-1 drugs like Wegovy and Zepbound , more and more people are opting for obesity medicines over gold-standard surgical treatments.  “On a population level, among a subset of commercially insured individuals, that is the tradeoff that is happening” said Thomas Tsai, th

Hospitals 362
article thumbnail

Why pharma megamergers may become a relic of the past

PharmaVoice

Despite pent up M&A demand, FTC scrutiny has had a chilling effect on pharma’s appetite for striking major deals.

163
163
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Editas, changing course again, looks to partner lead CRISPR therapy

BioPharma Dive

The gene editing company will focus on “in vivo” medicines, while seeking to license out or find a development partner for its clinical-stage treatment reni-cel.

117
117
article thumbnail

Novo joins Lilly in asking FDA for ban on GLP-1 compounding

pharmaphorum

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by these manufacturers.

article thumbnail

Drinking is cheaper than it’s been in decades. Lobbyists are fighting to keep it that way

STAT

For years, it has been a reliable way to cut back on the consumption of cigarettes and sugary drinks: raise taxes on them. So it might seem an obvious tactic to apply to alcohol, which contributes to untold injuries, diseases and deaths in the United States each year. That’s the thinking of advocates and state legislators across the country, who also see it as a way to pull in more revenue.

Hospitals 362
article thumbnail

2024 PharmaVoice 100s: Patient Champions

PharmaVoice

Leaders advancing health advocacy, DEI initiatives and better medicine access for patients.

242
242
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Vizient reports strides in 2023 DEI progress

vizient

The report includes insights across key performance indicators and features programs and solutions Vizient implements to ensure a diverse, equitable and inclusive work environment.

111
111
article thumbnail

GSK plans $800m US manufacturing investment

pharmaphorum

GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.The programme represents the largest capital spend by the UK drugmaker on production capacity to date and will double the size and capacity of GSK's existing medicines and vaccines facility in Marietta, Pennsylvania, creating around 200 new jobs.

Vaccines 112
article thumbnail

STAT+: Novo asks FDA to bar compounders from making Ozempic copies

STAT

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex for the pharmacies to safely make. Compounding pharmacies are typically allowed to make copies of drugs that are deemed to be in shortage by the FDA, which semaglutide has been for over two years.

article thumbnail

JB Pharma announces ESG commitments with launch of third sustainability report

Express Pharma

J.B. Chemicals & Pharmaceuticals (JB Pharma) has announced its Environmental, Social, and Governance (ESG) commitments with the release of its third Sustainability Report. The report highlights the company’s achievements in reducing its environmental impact and improving resource efficiency, marking a significant milestone in its dedication to sustainable growth.

111
111
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Pharmacies piloting access to GP records

The Pharmacist

IT suppliers are testing pharmacy access to GP records with some pharmacies using Cegedim Rx live in a pilot stage, it has been revealed. Speaking at the Pharmacy Show earlier this month, Tahmina Rokib, clinical lead at the clinical digital informatics, transformation directorate at NHS England (NHSE) said that Cegedim had been running a pilot […] The post Pharmacies piloting access to GP records appeared first on The Pharmacist.

117
117
article thumbnail

Gilead, MSD say HIV combo could be weekly, oral HIV drug

pharmaphorum

An antiretroviral combination developed by Gilead and MSD suppressed HIV with a single weekly oral dose in a phase 2 trial reported at IDWeek 2024

122
122
article thumbnail

STAT+: Ozempic linked to lower risk of Alzheimer’s diagnosis in observational study

STAT

Novo Nordisk’s drug Ozempic was linked to a lower risk of getting diagnosed with Alzheimer’s among people with type 2 diabetes, an analysis of medical records found, supporting the case for further research of the blockbuster GLP-1 drug in neurodegenerative diseases. Among the over 1 million people with diabetes whose records were included in the study, the overall risk of developing Alzheimer’s was already very low.

Diabetes 360
article thumbnail

Lupin appoints Claus Jepsen as President of Global Specialty

Express Pharma

Lupin has announced the appointment of Claus Jepsen as President of Global Specialty. Claus brings over three decades of experience in commercial strategy, portfolio management, and launch planning across Europe, Asia, and the United States. Claus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases. Prior to his role at Takeda, Claus was with GlaxoSmithKline, where he held various positions, including country head in Asia and Global Franchise Management in

108
108
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Pharmacy opening times cut by more than three million hours a year, CCA claims

The Pharmacist

An estimated 3.4 million hours of community pharmacy access is lost in England each year due to under-pressure premises reducing their opening hours, the Company Chemists' Association (CCA) has claimed. This is based on analysis of the Consolidated Pharmaceutical List that shows a net loss of almost 64,000 pharmacy weekly opening hours between September 2022 […] The post Pharmacy opening times cut by more than three million hours a year, CCA claims appeared first on The Pharmacist.

article thumbnail

UK launches scheme to boost dementia trial participation

pharmaphorum

UK scheme to tackle "historically low" numbers of people taking part in dementia trials launches with £20m in government funding

121
121
article thumbnail

Dietary experts advise skipping guidelines on ultra-processed foods — for now

STAT

If you were hoping to see where ultra-processed foods might fit in the next Dietary Guidelines for Americans, hold that thought. Scientific experts tasked with advising federal officials drafting the 2025-2030 Dietary Guidelines for Americans said the data were far too limited to draw conclusions. Meeting Monday, the first of two days of presentations, they discussed research findings to inform a report to the Department of Health and Human Services and the Department of Agriculture.

362
362
article thumbnail

Dr Reddy’s Laboratories among top 15 biotech and pharma employers in Science Magazine Survey

Express Pharma

Dr Reddy’s Laboratories has been recognised among the top employers in the global biotech and pharma sectors, according to the 2024 Top Biotech and Pharma Employers Survey by Science magazine. This marks the third consecutive year that Dr Reddy’s has secured a place in the survey’s top rankings. Dr Reddy’s first entered the list in 2022, ranked 18th.

105
105
article thumbnail

U.S. FDA approves Pfizer's RSV vaccine ABRYSVO® for adults aged 18 to 59 at increased risk for disease

World Pharma News

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) has approved ABRYSVO ® (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of lower respiratory tract disease (LRTD) caused by RSV in individuals 18 through 59 years of age who are at increased risk for LRTD caused by RSV.

Vaccines 105